Forced insurance coverage of chiropractic, naturopathic, and acupuncture services is not consistent with the goals of either the ACA or the AHCA. Whatever happens to Obamacare in the U.S. Senate, Section 2706 of the ACA should be repealed.
Make measles great again: A case study of the politicization of school vaccine requirements in Michigan
Protecting our children through school vaccine requirements has long had strong bipartisan support. Unfortunately, the antivaccine movement has had success linking "vaccine choice" with "freedom" and "parental rights", leading to a surge of right wing antivaccine activism that has undermined that bipartisan consensus. Two bills under consideration by the Michigan legislature represent a microcosm of what is going on in much of...
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans like Vice President Mike Pence for right-to-try, is it too late to stop this juggernaut and protect patients?
A week after Donald Trump was elected, I speculated about how he would affect medical science policy. Now, 80 days into the Trump administration, we have some observations.
Last week, in a surprise move Google delisted Mike Adams' Natural News website. Predictably, Adams immediately cried "Conspiracy!" and accused Google of punishing him for his support for "natural health" and Donald Trump. The truth appears to be that Adams violated one of Google's rules, leaving the question: What's the best way to fight fake news and fake medicine on the Internet?
The election of Donald Trump as President has emboldened antivaxers, because they quite rightly sense that he is one of them. His inauguration as President, combined with other trends, have led observers to ask the question: Are antivaxers winning, or will 2017 be the year of the antivaxer?
Donald Trump versus the FDA: Is the standard of evidence for drug approval actually too low rather than too high?
All of the candidates being considered by President Trump for FDA Commissioner believe that the FDA is too strict in its standards for approving new drugs. In a commentary in Nature last week, two bioethicists argued that, at least in terms of preclinical data, the standard of evidence is actually too low. Which is correct?
Donald Trump's three most likely picks for FDA Commissioner all favor loosening drug approval standards. Two are cronies of Peter Thiel, of which one believes that the FDA shouldn't require evidence of efficacy, only safety, and the other believes that a "Yelp for drugs" would do a better job than the FDA. The third candidate is a bona fide, honest-to-goodness pharma shill....
Trump and RFK Jr., both with anti-vaccine conspiracy beliefs, met to discuss forming a presidential panel on vaccines and autism. The exact outcome is uncertain, but the possibilities are frightening.
The election of Donald Trump was unexpected. Given Trump's history of antivaccine beliefs and conspiracy theories, coupled with a fervor for deregulation (a fervor shared by the Republican Congress), it is reasonable to fear what will happen to medical science policy during the next four years.